Hepatic blood flow regulation by stellate cells in normal and injured liver

Seminars in Liver Disease

Volumn 21, Issue 3, 2001, Pages 337-349

  Rockey, D C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endothelin; Endothelin receptor; Microcirculation; Nitric oxide; Nitric oxide synthase; Pericyte; Portal hypertension

Indexed keywords

BOSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; NITRIC OXIDE;

ANIMAL CELL; CONTROLLED STUDY; LIVER BLOOD FLOW; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER SINUSOID; MICROCIRCULATION; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; REVIEW; STELLATE CELL;

CELL PHYSIOLOGY; ENDOTHELIN-1; HUMANS; HYPERTENSION, PORTAL; LIVER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REGIONAL BLOOD FLOW;

EID: 0034804406     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17551     Document Type: Review

References (132)

1. Conceptual review of the hepatic vascular bed
2. Structure and function of sinusoidal lining cells in the liver
3. A dynamic and static study of hepatic arterioles and hepatic sphincters
4. Distensibility of hepatic venous resistance sites and consequences on portal pressure
5. Increased sinusoidal volume and solute extraction during retrograde liver perfusion
6. Morphological mechanisms for regulating blood flow through hepatic sinusoids
7. Differences in pericyte contractile function in rat cardiac and skeletal muscle microvasculatures
8. Recent advances in pericyte biology - Implications for health and disease
9. Regulatory mechanism of hepatic microcirculation: Involvement of the contraction and dilation of sinusoids and sinusoidal fenestrae
10. Nerves and perisinusoidal cells in human liver
11. Hepatic stellate cells and intralobular innervation in human liver cirrhosis
12. Expression of neural cell adhesion molecule (N-CAM) in perisinusoidal stellate cells of the human liver
13. Localization of intrahepatic portal vascular resistance
14. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
15. Nitric oxide and portal hypertension: Its role in the regulation of intrahepatic and splanchnic vascular resistance
16. Liver microvascular architecture: An insight into the pathophysiology of portal hypertension
17. Hepatic microvascular changes associated with development of liver fibrosis and cirrhosis
18. Hepatocyte swelling and portal hypertension
19. Portal hypertension in chronic hepatitis: Relationship to morphological changes
20. Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver
21. Fat-storing cells as liverspecific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients
22. Eicosanoid-mediated contractility of hepatic stellate cells
23. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus
24. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo
25. Endothelin-1 induces direct constriction of hepatic sinusoids
26. Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver
27. Endothelin-1 as a regulator of hepatic microcirculation: Sublobular distribution of effects and impact on hepatocellular secretory function
28. Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat
29. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat
30. Vasoactive effect of endothelin-1 on rat liver in vivo
31. Carbon monoxide: An endogenous modulator of sinusoidal tone in the perfused rat liver
32. Regulation of sinusoidal perfusion: In vivo methodology and control by endothelins
33. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance
34. Vitamin A-containing lipocytes and formation of type III collagen in liver injury
35. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver
36. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo
37. Phenotypic modulation in lipocytes in experimental liver fibrosis
38. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture
39. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction
40. Some historical and philosophical reflections on the myofibroblast concept
41. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators
42. Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis
43. Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism
44. ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1
45. The role of rho kinase in stellate cell activation following liver injury
46. Endothelin receptor subtypes in liver injury: Upregulation and differential signaling in myofibroblast contractility
47. Contraction of human hepatic stellate cells activated in culture: A role for voltage-operated calcium channels
48. Contractility of myofibroblasts during experimental liver cirrhosis
49. The endothelin system. A new target for therapeutic intervention
50. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide
51. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
52. The paracrine endothelin system: Pathophysiology and implications in clinical medicine
53. Growth regulatory properties of endothelins
54. Endothelin-1 promotes neointima formation after balloon angioplasty in the rat
55. Morphogenic effects of endothelin-1 on vascular smooth muscle cells
56. Endothelins stimulate mitogen-activated protein kinase cascade through either ETA or ETB
57. Changes in collagen metabolism in response to endothelin-1: Evidence for fibroblast heterogeneity
58. Endothelins in the normal and diseased kidney
59. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
60. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
61. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
62. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease
63. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium
64. Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells
65. Transcriptional regulation of the endothelin-1 gene by TNF-alpha
66. Endothelin-converting enzymes
67. Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium
68. ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1
69. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum
70. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1)
71. Molecular characterization of endothelin receptors
72. Endothelins
73. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo
74. Cellular signaling by peptides of the endothelin gene family
75. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
76. Elevated circulating plasma endothelin-1 concentrations in cirrhosis
77. Circulating levels of endothelin in cirrhosis
78. Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: Relationships with the arterial pressure and renal function
79. Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells
80. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites
81. Effect of endothelin-1 on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study
82. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli
83. Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function
84. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension
85. Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: Possible involvement of proinflammatory cytokines
86. Expression of endothelin-1 in pancreatic tissue of patients with chronic pancreatitis
87. Endothelin-1 immunoreactivity and mRNA in the transplanted human heart
88. Localization of endothelin-1 and its binding sites in scleroderma skin
89. Circulating endothelin-1 levels in systemic sclerosis subsets - A marker of fibrosis or vascular dysfunction?
90. Increased endothelin expression in a rat cardiac allograft model of chronic vascular rejection
91. Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing
92. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1
93. Endothelin association with the cultured rat Kupffer cell: Characterization and regulation
94. The endothelin-1 binding site in rat liver tissue: Light- and electron-microscopic autoradiographic studies
95. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats
96. Effect of adrenomedullin on hepatic pericytes (stellate cells) of the rat
97. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility
98. Human hepatic stellate cells secrete adrenomedullin: Potential autocrine factor in the regulation of cell contractility
99. The L-arginine-nitric oxide pathway
100. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
101. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme
102. Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform
103. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase
104. The nitric oxide synthase family of proteins
105. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress
106. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene
107. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms
108. Induction of calcium-dependent nitric oxide synthases by sex hormones
109. Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth
110. Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization
111. Agonist-modulated palmitoylation of endothelial nitric oxide synthase
112. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling
113. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo
114. The endothelial nitric-oxide synthase-caveolin regulatory cycle
115. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
116. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo
117. The discovery of nitric oxide as the endogenous nitrovasodilator
118. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
119. Nitric oxide modulates hepatic vascular tone in normal rat liver
120. Administration of L-arginine, the physiological precursor of nitric oxide, reduces portal perfusion pressure and ameliorates hepatic hyperreactivity in experimental cirrhosis
121. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia
122. Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en-Y choledocho-jejunostomy in the rat
123. Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells
124. Intralobular innervation and lipocyte contractility in the liver
125. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids
126. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension
127. Nitric oxide in liver injury
128. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats
129. The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver
130. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance
131. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension
132. Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs